Semi-annual Performance Forecast for 2026
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
The forecast suggests a net profit attributable to the parent company will be negative, although there is a slight improvement compared to the previous year. The company cites changes in the macroeconomic environment and pricing pressures from healthcare policies as key reasons for the anticipated losses. Despite the forecasted losses, the company reports improvements in operational efficiency and a shift to profitability in the second quarter of the year.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Cowealth Medical China Co., Ltd. on 6ix
Earlier from Cowealth Medical China
- Brief Report on Cumulative Operating Revenue for January?June 2026
- Announcement on Shareholding Reduction Plan of Controlling Shareholder
- Announcement on Progress in Litigation
- Brief Report of Accumulative Operating Revenue for January-May 2026
- Brief Report of Accumulative Operating Revenue for January-April 2026
Later from Cowealth Medical China
- Brief Report on Cumulative Operating Revenue for January–July 2026
- Announcement on Provision for Asset Impairment Losses for the First Half of 2026
- Announcement on Outline of the 2026 Semi-annual Performance Briefing
- Announcement on Attending the 2026 Collective Reception Day for Listed Companies in Shanghai Jurisdiction and Interim Performance Briefing
- Brief Report on Cumulative Operating Revenue for January–August 2026
Follow Cowealth Medical China into a list and get an email when it puts out news.
Follow Cowealth Medical China